MedPath

A clinical study on siddha trail drug karanthai chooranan (Int) and karappan ennai (Ext) in patients having eczema

Phase 2
Conditions
Health Condition 1: null- Karapan (Eczema)
Registration Number
CTRI/2018/05/013617
Lead Sponsor
Govt siddha medical college
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Itching,Erythema,Papule,Macule,Pustules,Vesicules,Oozing ,Crusting,Scaling

Lichenification

Exclusion Criteria

Solardermatitis,Cardiovascular diseases, any skin disease other than eczema,Pregnant women and lactating mother,auto immune disorder,Diabetes mellitus,secondary infection,HIV +ve

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Reduction in clinical symptoms like( itching, scaling ,vesicle, oozing and Lichenification). <br/ ><br>Reduction in EASI Score (Eczema area severity index)Timepoint: nil
Secondary Outcome Measures
NameTimeMethod
ilTimepoint: Nil
© Copyright 2025. All Rights Reserved by MedPath